AI assistant
Sending…
Boule Diagnostics — Major Shareholding Notification 2019
Aug 13, 2019
3143_iss_2019-08-13_7e4ae0fe-31fc-4e7a-b790-3dc2a0634b19.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Boule Diagnostic AB
Holder
Nordea Funds Ltd
Instrument
| Instrument | Equity SE0011231158 | |
|---|---|---|
| Before the transaction | ||
| Shares | Data not given* | |
| Voting rights | Data not given* | |
| Transaction | ||
| Reason for major shareholding notification Buy | ||
| Date | 12/08/2019 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 1,121,976 | |
| Directly held voting rights | 1,121,976 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 5.77845 % | |
| Directly held voting rights | 5.77845 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 5.77845 % | 1,121,976 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 5.77845 % | 1,121,976 |
| Group total holdings | ||
| Voting rights 1,121,976 |
||
| Percentage of voting rights 5.77845 | ||
| Published | ||
| 13/08/2019 10:32 | ||
| Contact | ||
| Name Rasmus Kroner |
||
| Phone +45 55 472 411 Email [email protected] |
||
| *Source of information has chosen not to submit the data | ||
| CLOSE |
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Boule Diagnostics
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Interim / Quarterly Report
2026
Apr 28
Interim / Quarterly Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 13
Annual Report
2026
Apr 10
Interim / Quarterly Report
2026
Feb 11
Earnings Release
2026
Feb 11
Board/Management Information
2025
Dec 30
Board/Management Information
2025
Dec 30